title: Tumour necrosis factor-alpha gene -238G/A promoter polymorphism associated with a more rapid onset of lipodystrophy.
authors.affiliation: Centre for Clinical Immunology and Biomedical Statistics, and Department of Clinical Immunology and Biochemical Genetics, Royal Perth Hospital, Perth, Western Australia.
authors.forename: David
authors.initials: D
authors.lastname: Nolan
authors.forename: Corey
authors.initials: C
authors.lastname: Moore
authors.forename: Alison
authors.initials: A
authors.lastname: Castley
authors.forename: David
authors.initials: D
authors.lastname: Sayer
authors.forename: Cyril
authors.initials: C
authors.lastname: Mamotte
authors.forename: Mina
authors.initials: M
authors.lastname: John
authors.forename: Ian
authors.initials: I
authors.lastname: James
authors.forename: Simon
authors.initials: S
authors.lastname: Mallal
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D015331:Cohort Studies; D018450:Disease Progression; D020022:Genetic Predisposition to Disease; D039682:HIV-Associated Lipodystrophy Syndrome / Q000235:genetics*; D006801:Humans; D011110:Polymorphism, Genetic; D011401:Promoter Regions, Genetic / Q000235:genetics; D016016:Proportional Hazards Models; D012307:Risk Factors; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
chemical_list: D014409:Tumor Necrosis Factor-alpha